The Black Womb Crisis: Endometrial Cancer and Gynecologic Health Equity with Dr. Kemi Dole

Short summary

The podcast features an in depth conversation with Dr. Kemi Dole, a gynecologic oncologist and health equity scientist, about her book A Terrible Strength and the concept of the Black womb crisis. The discussion expands the focus from maternal mortality to womb health across the life course, highlighting how fibroids, endometriosis, and gynecologic cancers disproportionately affect Black women. The host and guest examine diagnostic biases, data gaps, and the importance of holistic patient care in an era of misinformation and wellness trends. They also address advancing guidelines, public health funding, and the need to redefine women’s health beyond pregnancy and contraception.

• Womb as a life course concept, not only a pregnancy issue
• Diagnostic disparities and delayed endometrial cancer diagnosis due to fibroids and irregular cycles
• Public health, funding, and policy changes for women’s gynecologic health
• Personal experiences with care emphasize a need for trust and holistic communication

Understanding the podcast

The podcast features Rachel Feltman interviewing Dr. Kemi Dole about her book A Terrible Strength. Dr. Dole is a clinically trained gynecologic oncologist and a health equity scientist who argues for reframing Black maternal health as a broader womb crisis. The conversation situates endometrial cancer within a continuum of gynecologic conditions that affect Black women across the life course, including fibroids and endometriosis. The host and guest explore how race and gender intersect to shape diagnosis, treatment, and health outcomes, and they discuss how the medical community can respond with a holistic, evidence based approach that honors patient experiences.

Key concepts and framing

The central idea is the womb as a life span organ that requires attention beyond pregnancy. The discussion emphasizes that gynecologic cancers cannot be addressed in isolation from non cancer womb conditions that often precede or accompany cancer, and that Black women frequently experience delays in diagnosis due to anatomical differences, cycles, and access barriers. The book argues for a narrative that integrates patient voices with scientific data to guide interventions across the lifespan.

From data to lived experience

A major theme is how traditional diagnostic pathways can misrepresent or miss risk in Black women. The ultrasound based endometrial thickness threshold for postmenopausal bleeding, a common diagnostic trigger, may be less accurate in Black women because of higher rates and different patterns of fibroids. This mismatch contributes to false negatives and delayed cancer detection. The interview highlights the importance of inclusive trial design and representation in diagnostic studies to ensure equitable care.

Clinical practice and patient care

Dr. Dole notes a rising public interest in gynecologic issues and a growing demand among patients for reliable, evidence based information. She discusses how clinicians must adapt their communication and engage patients in decision making, particularly in a media environment filled with misinformation. The conversation also touches on the emotional toll of negative care experiences and the need for respectful, trauma informed care in routine gynecologic services such as Pap tests and beyond.

Implications for policy and the future

The discussion anticipates shifts in public health infrastructure, cancer funding, and the NIH portfolio for women’s health research. It also calls for expanding access to gynecologic care and for recognizing the impact of reproductive freedoms on overall women health. The dialogue closes with an optimistic view that earlier detection, improved treatments, and stronger advocacy could alter the trajectory of endometrial cancer and related conditions for Black women over the coming decades.